During the past decade, Medical Company "ARS" conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Company "ARS"" #1 collaborator was "ClinPhone, Inc." with 1 trials as a collaborator, "Covance" with 1 trials as a collaborator, "Dainippon Sumitomo Pharma America" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Medical Company "ARS"" are "Overactive Bladder Syndrome (OABS)" (1 trials) and "Uterine Fibroids" (1 trials). Many other conditions were trialed in "Medical Company "ARS"" in a lesser frequency.

Most popular intervention types in "Medical Company "ARS"" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "PGL4001 10 mg" (1 trials), "PGL4001 5 mg" (1 trials), "Placebo" (1 trials) and "SMP-986" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical Company "ARS"" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Medical Company "ARS"". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Medical Company "ARS", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medical Company "ARS", 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".